Anti-Vascular Endothelial Growth Factor Drug Treatment of Diabetic Macular Edema: The Evolution Continues

E-ISSN： 1875-6417|8|4|237-246

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.8, Iss.4, 2012-07, pp. : 237-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: A New Cause of Hypertension

Current Hypertension Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite

Anti‐epidermal or anti‐vascular endothelial growth factor as first‐line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 231-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravitreal Triamcinolone for the Treatment of Diabetic Macular Edema

Current Diabetes Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 99-112

Bentham Science Publishers

Access to resources Recommend Favorite

Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?

By Sang D.

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1570-1573

Springer Publishing Company

Access to resources Recommend Favorite

Pegaptanib Sodium for the Treatment of Proliferative Diabetic Retinopathy and Diabetic Macular Edema

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 33-38

Bentham Science Publishers

Access to resources Recommend Favorite